Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × Capecitabine × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 60 Colorectal Neoplasms 36 Rectal Neoplasms 33 Stomach Neoplasms 31 Triple Negative Breast Neoplasms 23 Neoplasm Metastasis 19 Colonic Neoplasms 16 Esophageal Neoplasms 15 Neoplasms 13 Nasopharyngeal Carcinoma 10 Adenocarcinoma 10 Cholangiocarcinoma 9 Biliary Tract Neoplasms 9 Adenocarcinoma Of Esophagus 9 Pancreatic Neoplasms 8 Recurrence 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Locally Advanced Rectal Cancer 7 Brain Neoplasms 6 Anus Neoplasms 6 Neuroendocrine Tumors 5 Gallbladder Neoplasms 5 HER2-positive Breast Cancer 4 Gastrointestinal Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Colorectal Cancer Metastatic 4 Squamous Cell Carcinoma of Head and Neck 3 Pathologic Complete Response 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3

Interventions

Cyclophosphamide 4 fludarabine 2 Temozolomide 2 Radiotherapy 2 Automobiles 2 omburtamab I-131 1 ibrutinib 1 gallium Ga 68 dotatate 1 belzutifan 1 Zoledronic Acid 1 Vincristine 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Pemetrexed 1 ONC206 1 Nivolumab 1 Infusions, Intravenous 1 HhAntag691 1 Gemcitabine 1 Exercise 1 Etoposide 1 Eflornithine 1 Drug Therapy 1 Craniospinal Irradiation 1 Cisplatin 1 CLR1404 1 Blood Specimen Collection 1 1-methyltryptophan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡